Stephen R Durham Selected Research

Asthma (Bronchial Asthma)

4/2024	Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
10/2023	Prevention Is Better than Cure: Impact of Allergen Immunotherapy on the Progression of Airway Disease.
11/2022	Neutrophil Extracellular Traps in Asthma: Friends or Foes?
1/2022	Allergen immunotherapy for long-term tolerance and prevention.
1/2022	Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
12/2021	Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
1/2021	Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
12/2019	Perspectives in allergen immunotherapy: 2019 and beyond.
11/2019	2019 ARIA Care pathways for allergen immunotherapy.
1/2019	Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen R Durham Research Topics

Disease

40	Allergic Rhinitis 04/2024 - 05/2002
32	Asthma (Bronchial Asthma) 04/2024 - 05/2002
31	Hypersensitivity (Allergy) 04/2024 - 03/2002
22	Seasonal Allergic Rhinitis (Hay Fever) 01/2021 - 01/2002
15	Inflammation (Inflammations) 11/2022 - 12/2003
13	Rhinitis 10/2023 - 12/2003
9	Anaphylaxis (Anaphylactic Shock) 01/2021 - 03/2002
4	Peanut Hypersensitivity (Peanut Allergy) 01/2023 - 05/2015
3	Eosinophilia 01/2021 - 01/2016
3	Bites and Stings (Sting) 01/2019 - 03/2004
2	Conjunctivitis 04/2024 - 02/2024
2	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2021 - 01/2011
2	Nasal Polyps (Nasal Polyp) 01/2019 - 10/2017
2	Rhinosinusitis 01/2019 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 12/2008 - 11/2004
1	Immediate Hypersensitivity 01/2023
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Sleep Deprivation 12/2019
1	Perennial Allergic Rhinitis 10/2016
1	Polyps 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Airway Remodeling 12/2015
1	Hepatitis 04/2013
1	Hepatitis B 04/2013
1	Wounds and Injuries (Trauma) 02/2013
1	Pneumonia (Pneumonitis) 02/2013
1	Disease Progression 10/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2009
1	Fibrosis (Cirrhosis) 12/2009
1	Cough 11/2009
1	Chronic Cough 11/2009

Drug/Important Bio-Agent (IBA)

44	AllergensIBA 04/2024 - 01/2002
28	Immunoglobulin E (IgE)IBA 12/2021 - 01/2002
10	TabletsIBA 04/2024 - 04/2006
6	CytokinesIBA 11/2022 - 01/2002
6	AntibodiesIBA 12/2021 - 04/2003
5	Immunoglobulin G (IgG)IBA 12/2021 - 05/2011
5	Peptides (Polypeptides)IBA 01/2019 - 04/2013
4	Arthropod VenomsIBA 01/2022 - 01/2019
4	EpitopesIBA 12/2021 - 04/2013
4	Immunoglobulin A (IgA)IBA 12/2021 - 01/2004
4	AntigensIBA 01/2019 - 11/2004
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2016
3	ChemokinesIBA 11/2022 - 12/2003
3	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2018 - 04/2005
3	GrazaxIBA 01/2015 - 01/2010
3	VaccinesIBA 03/2014 - 05/2008
3	Interleukin-10 (Interleukin 10)IBA 12/2008 - 03/2004
2	VenomsIBA 01/2023 - 06/2004
2	Interleukin-13IBA 01/2021 - 01/2016
2	Histamine (Histamine Dihydrochloride)FDA Link 06/2017 - 08/2013
2	Omalizumab (Xolair)FDA Link 12/2016 - 09/2007
2	Anti-Allergic Agents (Antiallergic Agents)IBA 02/2016 - 05/2011
2	anti-IgE antibodiesIBA 01/2016 - 09/2007
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2014 - 03/2014
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 12/2009
2	levocetirizine FDA LinkGeneric 10/2006 - 10/2004
1	Neutralizing AntibodiesIBA 03/2024
1	Histones (Histone)IBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	Peroxidase (Myeloperoxidase)IBA 11/2022
1	Monoclonal AntibodiesIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	CI 22IBA 12/2019
1	Annexin A5IBA 01/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018
1	OvalbuminIBA 01/2018
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 12/2017
1	mepolizumabIBA 10/2017
1	Interleukin-33IBA 01/2016
1	Extracellular Matrix ProteinsIBA 12/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2015
1	CollagenIBA 12/2015
1	Silk FDA Link 11/2014
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2014
1	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 04/2014
1	Wasp Venoms (Venom, Wasp)IBA 01/2014
1	Recombinant Fusion ProteinsIBA 04/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2013
1	Interleukin-22 (IL-22)IBA 02/2013
1	Tryptases (Tryptase)IBA 06/2012
1	Eosinophil Cationic ProteinIBA 06/2012
1	Capsaicin (Zostrix)FDA Link 11/2009
1	Cholecalciferol (Vitamin D3)FDA Link 12/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2008
1	SteroidsIBA 12/2008
1	aluminum sulfate (alum)IBA 05/2008
1	Cytidine DeaminaseIBA 01/2007

Therapy/Procedure

49	Immunotherapy 04/2024 - 01/2002
11	Therapeutics 11/2023 - 05/2002
5	Drug Therapy (Chemotherapy) 11/2022 - 02/2006
3	Injections 06/2017 - 05/2008
2	Aftercare (After-Treatment) 02/2011 - 01/2010
1	Biological Therapy 01/2016
1	Intradermal Injections 08/2013
1	Duration of Therapy 01/2011